| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/08/2006 | EP0861894B1 Differentiation-suppressive polypeptide |
| 03/08/2006 | EP0804480B1 Purified thrombopoietin and method of making it |
| 03/08/2006 | EP0800532B1 Improved cyclic crf agonists |
| 03/08/2006 | EP0781327B1 Production of hydroxylated fatty acids in genetically modified plants |
| 03/08/2006 | EP0755406B1 Method and product for regulating cell responsiveness to external signals |
| 03/08/2006 | EP0733109B1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 03/08/2006 | EP0553291B1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 03/08/2006 | CN1745175A Active immunization to generate antibodies to soluble A-beta |
| 03/08/2006 | CN1745100A 因子Ⅷ多肽 Ⅷ factor polypeptides |
| 03/08/2006 | CN1745099A 修饰的可溶性t细胞受体 Modified soluble t-cell receptor |
| 03/08/2006 | CN1745098A Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 03/08/2006 | CN1745097A Tumour tag and its use |
| 03/08/2006 | CN1745094A Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 03/08/2006 | CN1744919A Method and composition for treating tumors by selective induction of apoptosis |
| 03/08/2006 | CN1744914A Human growth hormone crystals and methods for preparing them |
| 03/08/2006 | CN1744913A Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 03/08/2006 | CN1744912A Stabilized preparation containing protein |
| 03/08/2006 | CN1744911A NOGO,CASPR,F3,NB-3 for treatment of injury and disease to the central nervous system |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744909A Orally administered peptides synergize statin activity |
| 03/08/2006 | CN1744908A Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 03/08/2006 | CN1744907A Oral lactoferrin in the treatment of sepsis |
| 03/08/2006 | CN1744905A Topical anti-infective formulations |
| 03/08/2006 | CN1744893A Method for treating ischemic stroke with melatonin |
| 03/08/2006 | CN1744886A Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 03/08/2006 | CN1744823A Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 03/08/2006 | CN1743456A Modulators of the function of receptors of the TNF/NGF receptor family and other protein |
| 03/08/2006 | CN1743452A Phosphokinase and its use |
| 03/08/2006 | CN1743002A Iron-supplementing preparation |
| 03/08/2006 | CN1743001A Efficient mixture preparation for intensifying solid tumor cell chemical therapeutic sensitivity |
| 03/08/2006 | CN1743000A Parathyroid hormone transnosal preparation and preparing method |
| 03/08/2006 | CN1742999A Method for preparing nano freeze-dried powder comprising human-body calcitonin gene relative peptide and product made therefrom and use thereof |
| 03/08/2006 | CN1742998A Use of interferon alpha-1b for preparing medicine for preventing and treating upper respiratory tract inflammation |
| 03/08/2006 | CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease |
| 03/08/2006 | CN1742996A Changsanye-factor oral liquor and clinical use |
| 03/08/2006 | CN1742778A Cervus and cucumis polypeptide injection composition and preparing method |
| 03/08/2006 | CN1742749A Gugua polypeptide medicinal composition for injetion and preparing method therefor |
| 03/08/2006 | CN1742737A Glucocorticoid capsule type inhaling atomized powder and preparation method |
| 03/08/2006 | CN1742706A Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 03/08/2006 | CN1742622A Health-care product and preparing method |
| 03/08/2006 | CN1244700C Human acetylcholinesterase isomer protein (AR-ACHE) and its gene coding sequence |
| 03/08/2006 | CN1244694C Yak blood superoxide dismutase preparation method |
| 03/08/2006 | CN1244595C Tumor suppressor protein and its application |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/08/2006 | CN1244375C Human liver regeneration related protein and its application |
| 03/08/2006 | CN1244337C Natural medicated health food for preventing and treating diabetes and cardiac vascular diseases induced thereby |
| 03/08/2006 | CN1244329C Use of anti-pregnant-hormone for preparing medicine for inhibiting accelerated endometrial maturation of female mammals |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7009042 fusion proteins; site-directed mutagenesis; host cells |
| 03/07/2006 | US7009039 obtained by mixing plasma proteins fibrinogen and Factor XIII with thrombin and at least one anti-fibrinolytic agent (tranexamic acid) in absence of organic chelating agent; implant for tissue engineering |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7009035 Peptide for use in the diagnosis and treatment of tumors |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008928 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
| 03/07/2006 | US7008927 Pralmorelin-containing nasal drop preparations |
| 03/07/2006 | US7008926 Blood coagulation factor XIII for treating platelet disorders |
| 03/07/2006 | US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception |
| 03/07/2006 | US7008924 heterologous amino acid sequence is fused to another amino acid sequence wherein the heterologous amino acid sequence is a peptide that:aids in detection, isolation, oligomerization, stability of the fusion polypeptide; treating eating disorders |
| 03/07/2006 | US7008923 Glycopeptide phosphonate derivatives |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008920 comprising pharmacologically active substance, drug absorbefacient and taurine compound or polyamine; suppressing or preventing damage of the intestinal mucous membrane |
| 03/07/2006 | US7008781 Method of enhancing the biological activity of ligands |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008763 Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue |
| 03/07/2006 | US7008649 administering compositions of eugenol and forskolin; for treating and/or preventing soft tissue cancer in mammals |
| 03/07/2006 | US7008644 Method and apparatus for producing dry particles |
| 03/07/2006 | US7008643 Delivery system for biological material |
| 03/07/2006 | US7008634 includes growth factors and extracellular matrix molecules flexibly tethered to a support medium; used to stimulate cell and tissue growth by enhancment of the biological response to the growth factor; liver cells |
| 03/07/2006 | US7008633 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent |
| 03/07/2006 | US7008627 dermocosmetic blends useful for improving and treating hyperreactive skin conditions, allergic-type reactions and/or intolerance; anti-radical, anti-inflammatory and anti-allergenic; immunomodulatory activity |
| 03/07/2006 | US7008624 IL-15 or muteins covalently bound to group (PEG, PVP,PVA, dextran, gelatin) that sterically interferes with signal transduction through IL-15 receptor complex; allograft rejection and graft-versus-host disease |
| 03/07/2006 | US7008623 Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/07/2006 | US7008621 Regulation of apoptosis in aquatic organisms by aquabirnavirus |
| 03/02/2006 | WO2006023976A2 Formulations and methods for modulating satiety |
| 03/02/2006 | WO2006023971A2 Inhibition of mitogen-activated protein kinases in cardiovascular disease |
| 03/02/2006 | WO2006023910A2 Method of treating, preventing, inhibiting or reducing damage to cardiac tissue |
| 03/02/2006 | WO2006023893A2 Methods for modulating angiogenesis and apoptosis with apelin compositions |
| 03/02/2006 | WO2006023795A2 Amphipathic proteinaceous coating on nanoporous polymer |
| 03/02/2006 | WO2006023782A2 Refolding transforming growth factor beta family proteins |
| 03/02/2006 | WO2006023781A2 Neublastin variants |
| 03/02/2006 | WO2006023714A2 Dithiocarbamate derivatives and their use for treating cancer |
| 03/02/2006 | WO2006023684A2 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 03/02/2006 | WO2006023629A2 Treatment of pediatric multiple sclerosis |
| 03/02/2006 | WO2006023623A2 Methods of healing wounds by administering human il-18 |
| 03/02/2006 | WO2006023608A2 Growth-hormone secretagogues |
| 03/02/2006 | WO2006023530A2 Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
| 03/02/2006 | WO2006023452A2 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 03/02/2006 | WO2006023396A2 Vla-4 antagonists |
| 03/02/2006 | WO2006023367A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023358A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023356A2 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023121A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in white adipose tissue (13) |
| 03/02/2006 | WO2006022682A2 Method and compositions for treating diseases targeting cd49b |
| 03/02/2006 | WO2006022457A1 Synoviolin transgenic flies |
| 03/02/2006 | WO2006022301A1 Liquid preparation of physiologically active peptide |
| 03/02/2006 | WO2006021954A2 Peptide inhibitors for mediating stress responses |